114 related articles for article (PubMed ID: 3109868)
1. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
[TBL] [Abstract][Full Text] [Related]
2. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
[TBL] [Abstract][Full Text] [Related]
3. [Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].
Busch J; Hammer M; Brunkhorst R; Wagener P
Z Rheumatol; 1988; 47(3):156-60. PubMed ID: 3213262
[TBL] [Abstract][Full Text] [Related]
4. Intestinal permeability in patients with Crohn's disease and their first-degree relatives.
Howden CW; Gillanders I; Morris AJ; Duncan A; Danesh B; Russell RI
Am J Gastroenterol; 1994 Aug; 89(8):1175-6. PubMed ID: 8053430
[TBL] [Abstract][Full Text] [Related]
5. Measurement of intestinal permeability using 51Cr-EDTA.
Peled Y; Watz C; Gilat T
Am J Gastroenterol; 1985 Oct; 80(10):770-3. PubMed ID: 3929593
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
Howden CW; Robertson C; Duncan A; Morris AJ; Russell RI
Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
[TBL] [Abstract][Full Text] [Related]
7. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
[TBL] [Abstract][Full Text] [Related]
8. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease.
Issenman RM; Jenkins RT; Radoja C
Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.
Jenkins RT; Jones DB; Goodacre RL; Collins SM; Coates G; Hunt RH; Bienenstock J
Am J Gastroenterol; 1987 Nov; 82(11):1159-64. PubMed ID: 3118697
[TBL] [Abstract][Full Text] [Related]
10. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
[TBL] [Abstract][Full Text] [Related]
11. Application of the 51Cr-EDTA urinary recovery test for assessment of intestinal permeability in the horse.
Escala J; Gatherer ME; Voûte L; Love S
Res Vet Sci; 2006 Apr; 80(2):181-5. PubMed ID: 16143355
[TBL] [Abstract][Full Text] [Related]
12. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man.
Oman H; Blomquist L; Henriksson AE; Johansson SG
Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
[TBL] [Abstract][Full Text] [Related]
14. Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases.
Andre C; Descos L; Minaire Y
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():113-7. PubMed ID: 2128072
[TBL] [Abstract][Full Text] [Related]
15. Is an increased intestinal permeability a valid predictor of relapse in Crohn disease?
Jørgensen J; Ranløv PJ; Bjerrum PJ; Diemer H; Bisgaard K; Elsborg L
Scand J Gastroenterol; 2001 May; 36(5):521-7. PubMed ID: 11346207
[TBL] [Abstract][Full Text] [Related]
16. Increased intestinal permeability in active pulmonary sarcoidosis.
Wallaert B; Colombel JF; Adenis A; Marchandise X; Hallgren R; Janin A; Tonnel AB
Am Rev Respir Dis; 1992 Jun; 145(6):1440-5. PubMed ID: 1596016
[TBL] [Abstract][Full Text] [Related]
17. Assessment of canine intestinal permeability, using 51Cr-labeled ethylenediaminetetraacetate.
Hall EJ; Batt RM; Brown A
Am J Vet Res; 1989 Dec; 50(12):2069-74. PubMed ID: 2514618
[TBL] [Abstract][Full Text] [Related]
18. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease.
Pironi L; Miglioli M; Ruggeri E; Levorato M; Dallasta MA; Corbelli C; Nibali MG; Barbara L
Dig Dis Sci; 1990 May; 35(5):582-8. PubMed ID: 1691967
[TBL] [Abstract][Full Text] [Related]
19. [Increased intestinal permeability to 51 Cr-EDTA among children with persistent diarrhea].
Sawamura R; Fernandes MI; Troncon LE; Iazigi N
Arq Gastroenterol; 1997; 34(1):55-61. PubMed ID: 9458961
[TBL] [Abstract][Full Text] [Related]
20. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.
Jenkins RT; Ramage JK; Jones DB; Collins SM; Goodacre RL; Hunt RH
Clin Invest Med; 1988 Apr; 11(2):151-5. PubMed ID: 3135136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
